(Q35879798)

10 August 2017

1 reference

title

Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy (English)

1 reference

10 August 2017

1 reference

Tracy A Glauser

1

1 reference

10 August 2017

publication date

1 October 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

5 Suppl 3

1 reference

10 August 2017

page(s)

S25-32

1 reference

Psychiatric syndromes related to antiepileptic drugs

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Forced normalization: clinical and therapeutic relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Behavioural effects of the new anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Cognitive and behavioral effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Neuropsychological effects of epilepsy and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Neuropsychological effects of carbamazepine and phenytoin: a reanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Depression in epilepsy: etiology, phenomenology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Advancing the medical management of epilepsy: disease modification and pharmacogenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

The importance of drug interactions in epilepsy therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Effect of anticonvulsants on plasma haloperidol and thioridazine levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

The pharmacologic basis of antiepileptic drug action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Voltage-activated calcium channels: targets of antiepileptic drug therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Prophylactic diazepam or phenobarbitone in febrile convulsions: a prospective, controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Anti-epileptic therapy and behaviour disturbances in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Side effects of phenobarbital in toddlers; behavioral and cognitive aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions. A double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Influence of phenobarbital on the psychomotor development and behaviour in preschool children with convulsions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Barbiturate anticonvulsants: a neuropsychological and quantitative electroencephalographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Effectiveness and toxicity of phenobarbital, primidone, and sodium valproate in the prevention of febrile convulsions, controlled by plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Prevention of recurrent febrile convulsions--a randomized therapeutic assay: sodium valproate, phenobarbital and placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Efficacy of gabapentin therapy in children with refractory partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Vigabatrin in the treatment of epilepsy in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Psychotic and severe behavioural reactions with vigabatrin: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Adverse behavioral reactions in children treated with carbamazepine (Tegretol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Valproic acid versus ethosuximide in the treatment of absence seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

The Efficacy of Lamotrigine in Children and Adolescents with Refractory Generalized Epilepsy: A Randomized, Double-Blind, Crossover Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Lamotrigine treatment in childhood drug resistant epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Oxcarbazepine in the treatment of childhood epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Treatment of Intractable Childhood Epilepsy with High-Dose Valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Zonisamide in pediatric epilepsy: review of the Japanese experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Psychotic episodes during zonisamide treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A pilot study of topiramate in children with Lennox-Gastaut syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Topiramate for intractable childhood epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A pilot study of topiramate in the treatment of infantile spasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Long-term response to topiramate in patients with West syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Tolerability of topiramate in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Topiramate: efficacy and tolerability in children according to epilepsy syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

A Double-blind Study of Clonazepam in the Treatment of Therapy-resistant Epilepsy in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2004.06.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2004.06.013

1 reference

10 August 2017

1 reference